| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $196.5M | +229.7% |
| Cost of Revenue | $19.1M | +283.6% |
| R&D Expense | $76.4M | -30.9% |
| SG&A Expense | $229.4M | +23.9% |
| Operating Income | -$128.4M | +46.7% |
| Income Tax | $647K | -79.2% |
| Net Income | -$140.0M | +46.6% |
| EPS (Basic) | -$1.16 | +69.3% |
| EPS (Diluted) | -$1.16 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.3M | -19.3% |
| Accounts Receivable | $73.1M | +183.1% |
| Inventory | $14.5M | +10.6% |
| Current Assets | $335.8M | +1.6% |
| Total Assets | $348.9M | +2.2% |
| Current Liabilities | $81.0M | +73.6% |
| Long-term Debt | $107.2M | -46.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$112.2M | +54.6% |
| Capital Expenditures | $143K | -66.6% |
| Investing Cash Flow | $28.8M | -84.0% |
| Financing Cash Flow | $66.2M | -34.7% |
| Free Cash Flow | -$112.3M | +54.6% |
| +69.3% |
| Total Liabilities |
| $191.3M |
| -24.3% |
| Stockholders' Equity | $157.5M | +77.7% |